Double-Blind, Randomized, Placebo-Controlled, Phase 1b, Pharmacodynamic Trial of TEV-56192 Following a Single Intravenous Administration in Healthy Participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507018-29-00

Acronym

TV56192-PD-10191

Enrollment

Registered

2024-02-22

Start date

2024-03-05

Completion date

2024-11-22

Last updated

2024-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pruritus

None listed

Sex/Gender

All

Age

18 Years to No maximum

Denmark

None listed

Source: EU CTIS · Data processed: Feb 4, 2026